company background image
PMCN-M logo

Pharmocann Global TASE:PMCN-M Stock Report

Last Price

₪1.77

Market Cap

₪3.9m

7D

-1.9%

1Y

-72.1%

Updated

27 Mar, 2024

Data

Company Financials

PMCN-M Stock Overview

Pharmocann Global Ltd engages in the multiplication, cultivation, production, and sale of cannabis for medical purposes.

PMCN-M fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health4/6
Dividends0/6

Pharmocann Global Ltd Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Pharmocann Global
Historical stock prices
Current Share Price₪1.77
52 Week High₪6.32
52 Week Low₪0.51
Beta-0.13
1 Month Change-10.17%
3 Month Change26.05%
1 Year Change-72.06%
3 Year Change-99.07%
5 Year Changen/a
Change since IPO-99.42%

Recent News & Updates

Recent updates

The Returns On Capital At Pharmocann Global (TLV:PMCN) Don't Inspire Confidence

Mar 30
The Returns On Capital At Pharmocann Global (TLV:PMCN) Don't Inspire Confidence

Should You Use Pharmocann Global's (TLV:PMCN) Statutory Earnings To Analyse It?

Feb 04
Should You Use Pharmocann Global's (TLV:PMCN) Statutory Earnings To Analyse It?

Pharmocann Global Ltd (TLV:PMCN) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?

Dec 31
Pharmocann Global Ltd (TLV:PMCN) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?

The Returns At Pharmocann Global (TLV:PMCN) Provide Us With Signs Of What's To Come

Nov 26
The Returns At Pharmocann Global (TLV:PMCN) Provide Us With Signs Of What's To Come

Shareholder Returns

PMCN-MIL PharmaceuticalsIL Market
7D-1.9%11.6%2.2%
1Y-72.1%-13.5%12.8%

Return vs Industry: PMCN-M underperformed the IL Pharmaceuticals industry which returned -13.5% over the past year.

Return vs Market: PMCN-M underperformed the IL Market which returned 12.8% over the past year.

Price Volatility

Is PMCN-M's price volatile compared to industry and market?
PMCN-M volatility
PMCN-M Average Weekly Movementn/a
Pharmaceuticals Industry Average Movement5.9%
Market Average Movement4.3%
10% most volatile stocks in IL Market8.4%
10% least volatile stocks in IL Market3.0%

Stable Share Price: PMCN-M has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine PMCN-M's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
199720Gil Paramedichttps://www.pharmacann.co.il

Pharmocann Global Ltd engages in the multiplication, cultivation, production, and sale of cannabis for medical purposes. It provides cannabis to treat patients with depression and Alzheimer's. The company produces tons of processed cannabis.

Pharmocann Global Ltd Fundamentals Summary

How do Pharmocann Global's earnings and revenue compare to its market cap?
PMCN-M fundamental statistics
Market cap₪3.93m
Earnings (TTM)-₪24.91m
Revenue (TTM)₪15.13m

0.3x

P/S Ratio

-0.2x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
PMCN-M income statement (TTM)
Revenue₪15.13m
Cost of Revenue₪27.35m
Gross Profit-₪12.22m
Other Expenses₪12.69m
Earnings-₪24.91m

Last Reported Earnings

Jun 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-11.18
Gross Margin-80.77%
Net Profit Margin-164.68%
Debt/Equity Ratio3.0%

How did PMCN-M perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.